Hempstract, Inc. (HPST) Stock
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG).
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Hempstract, Inc.
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.
Hempstract, Inc. is headquartered in US.
Hempstract, Inc. (HPST) stock trades at $0.03 with a market capitalization of $25.55M. The stock is valued at a price-to-earnings (P/E) ratio of -33.33, price-to-book of -25.37, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.04, and currently trades 25.0% below its 52-week high.
On profitability, Hempstract, Inc. generates a return on equity (ROE) of 125.29% — well above the market average, a sign of a high-quality business, return on capital employed of 46.06%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.hempstractlabs.com